UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Breast cancer therapy in China: Introducing the Special Collection

Cancer, 2024-04, Vol.130 (S8), p.1368-1370

2024

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all?

Cancer, 2021-09, Vol.127 (18), p.3302-3309

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies

Cancer, 2020-08, Vol.126 (15), p.3400-3416

2020

Link zum Volltext

Verfügbarkeit prüfen

When the personal becomes political: The impact of the Dobbs decision on women with cancer

Cancer, 2023-01, Vol.129 (2), p.171-174

2023

Link zum Volltext

Verfügbarkeit prüfen

Lymph node involvement: Positive about the role of the recurrence score in estrogen‐driven breast cancer?

Cancer, 2019-01, Vol.125 (2), p.177-180

2019

Link zum Volltext

Verfügbarkeit prüfen

Social media and clinical trials: The pros and cons gain context when the patient is at the center

Cancer, 2018-12, Vol.124 (24), p.4618-4621

2018

Link zum Volltext

Verfügbarkeit prüfen

Progress in breast cancer research amid the COVID‐19 gloom

Cancer, 2020-08, Vol.126 (S16), p.3809-3810

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (18), p.5045-5056

2014

Link zum Volltext

Verfügbarkeit prüfen

Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (23), p.9712-9722

2008

Link zum Volltext

Verfügbarkeit prüfen

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2479-2488

2008

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy for early‐stage HER2‐positive breast cancers: Time for a less‐is‐more approach?

Cancer, 2015-02, Vol.121 (4), p.517-526

2015

Link zum Volltext

Verfügbarkeit prüfen

The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2019-03, Vol.79 (5), p.982-993

2019

Link zum Volltext

Verfügbarkeit prüfen

Improving Outcomes for High-Risk Hormone Receptor-Positive Breast Cancer With CDK Inhibition

Journal of clinical oncology, 2022-04, Vol.40 (11), p.1142-1146

2022

Link zum Volltext

Verfügbarkeit prüfen

Proteomic Identification of Glycosylphosphatidylinositol Anchor-dependent Membrane Proteins Elevated in Breast Carcinoma

The Journal of biological chemistry, 2012-07, Vol.287 (30), p.25230-25240

2012

Link zum Volltext

Verfügbarkeit prüfen

Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study

Clinical cancer research, 2021-06, Vol.27 (11), p.3061-3068

2021

Link zum Volltext

Verfügbarkeit prüfen

Race, breast cancer, and prognosis: Where biology is queen?

Cancer, 2019-09, Vol.125 (18), p.3104-3106

2019

Link zum Volltext

Verfügbarkeit prüfen

Insulin-like Growth Factor-l-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2479-2488

2008

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer screening: Time for rational discourse

Cancer, 2014-09, Vol.120 (18), p.2800-2802

2014

Link zum Volltext

Verfügbarkeit prüfen

Age/Race Differences in HER2 Testing and in Incidence Rates for Breast Cancer Triple Subtypes: A Population-Based Study and First Report

Cancer, 2010-06, Vol.116 (11), p.2549-2559

2010

Link zum Volltext

Verfügbarkeit prüfen

Development and Therapeutic Options for the Treatment of Raloxifene-Stimulated Breast Cancer in Athymic Mice

Clinical cancer research, 2006-04, Vol.12 (7), p.2255-2263

2006

Link zum Volltext

Verfügbarkeit prüfen

21-Gene Recurrence Scores: Racial Differences in Testing, Scores, Treatment, and Outcome

Cancer, 2012-02, Vol.118 (3), p.788-796

2012

Link zum Volltext

Verfügbarkeit prüfen

Chemoprevention of breast cancer

The Lancet (British edition), 2006-04, Vol.367 (9520), p.1382-1383

O'Regan, Ruth M

2006

Link zum Volltext

Verfügbarkeit prüfen

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

CA: a cancer journal for clinicians, 2005-05, Vol.55 (3), p.145-163

2005

Link zum Volltext

Verfügbarkeit prüfen

New targeted therapies in breast cancer

Seminars in oncology, 2004-04, Vol.31 (2), p.20-25

2004

Link zum Volltext

Verfügbarkeit prüfen

Do tumors detected by mammography screening have a favorable prognosis?

JAMA : the journal of the American Medical Association, 2004-09, Vol.292 (9), p.1062

O'Regan, Ruth M

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

KollektionPublisher website

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Breast cancer therapy in China: Introducing the Special Collection

Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all?

Therapy after cyclin‐dependent kinase inhibition in metastatic hormone receptor‐positive breast cancer: Resistance mechanisms and novel treatment strategies

When the personal becomes political: The impact of the Dobbs decision on women with cancer

Lymph node involvement: Positive about the role of the recurrence score in estrogen‐driven breast cancer?

Social media and clinical trials: The pros and cons gain context when the patient is at the center

Progress in breast cancer research amid the COVID‐19 gloom

Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer

Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

Systemic therapy for early‐stage HER2‐positive breast cancers: Time for a less‐is‐more approach?

The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer

Improving Outcomes for High-Risk Hormone Receptor-Positive Breast Cancer With CDK Inhibition

Proteomic Identification of Glycosylphosphatidylinositol Anchor-dependent Membrane Proteins Elevated in Breast Carcinoma

Eribulin Plus Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase Ib/II Study

Race, breast cancer, and prognosis: Where biology is queen?

Insulin-like Growth Factor-l-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells

Breast cancer screening: Time for rational discourse

Age/Race Differences in HER2 Testing and in Incidence Rates for Breast Cancer Triple Subtypes: A Population-Based Study and First Report

Development and Therapeutic Options for the Treatment of Raloxifene-Stimulated Breast Cancer in Athymic Mice

21-Gene Recurrence Scores: Racial Differences in Testing, Scores, Treatment, and Outcome

Chemoprevention of breast cancer

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

New targeted therapies in breast cancer

Do tumors detected by mammography screening have a favorable prognosis?

Aktive Filter

Suchergebnisse filtern